The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Ron Waksman

MedStar Washington Hospital Center


DC 20010



Name/email consistency: high



  • MedStar Washington Hospital Center, Washington, DC 20010, USA. 2013
  • MedStar Washington Hospital Center/MedStar Health Research Institute, Washington, DC. Electronic address:. 2012
  • Division of Cardiology, Department of Internal Medicine, Washington Hospital Center, Washington, DC, USA -. 2002 - 2012
  • Cardiovascular Research Institute, Washington Hospital Center, Washington, District of Columbia. 2011
  • Washington Hospital Center, 110 Irving St, NW, Suite 4B-1, Washington, USA. 2003 - 2005


  1. FIRST: Fractional Flow Reserve and Intravascular Ultrasound Relationship Study. Waksman, R., Legutko, J., Singh, J., Orlando, Q., Marso, S., Schloss, T., Tugaoen, J., DeVries, J., Palmer, N., Haude, M., Swymelar, S., Torguson, R. J. Am. Coll. Cardiol. (2013) [Pubmed]
  2. Percutaneous Coronary Intervention With Second-Generation Paclitaxel-Eluting Stents Versus Everolimus-Eluting Stents in United States Contemporary Practice (REWARDS TLX Trial). Waksman, R., Ghali, M., Goodroe, R., Ryan, T., Turco, M., Ring, M., McGarry, T., Dobies, D., Shammas, N., Steinberg, D.H., Swymelar, S., Kaneshige, K., Torguson, R. Am. J. Cardiol. (2012) [Pubmed]
  3. Glycoprotein IIb/IIIa inhibitors and bivalirudin in patients undergoing percutaneous coronary intervention. Mahmoudi, M., Waksman, R. Minerva. Cardioangiol (2012) [Pubmed]
  4. In vivo comparison of a polymer-free Biolimus A9-eluting stent with a biodegradable polymer-based Biolimus A9 eluting stent and a bare metal stent in balloon denuded and radiated hypercholesterolemic rabbit iliac arteries. Waksman, R., Pakala, R., Baffour, R., Seabron, R., Hellinga, D., Chan, R., Su, S.H., Kolodgie, F., Virmani, R. Catheter. Cardiovasc. Interv (2011) [Pubmed]
  5. An innovative noninvasive respiratory stress test indicates significant coronary artery disease. Waksman, R., Sushinsky, S., Okubagzi, P., Landry, P., Torguson, R., Bui, A., Shiyovich, A., Scharf, S.M., Katz, A. Cardiovasc. Revasc. Med (2010) [Pubmed]
  6. A first-in-man, randomized, placebo-controlled study to evaluate the safety and feasibility of autologous delipidated high-density lipoprotein plasma infusions in patients with acute coronary syndrome. Waksman, R., Torguson, R., Kent, K.M., Pichard, A.D., Suddath, W.O., Satler, L.F., Martin, B.D., Perlman, T.J., Maltais, J.A., Weissman, N.J., Fitzgerald, P.J., Brewer, H.B. J. Am. Coll. Cardiol. (2010) [Pubmed]
  7. Early- and long-term intravascular ultrasound and angiographic findings after bioabsorbable magnesium stent implantation in human coronary arteries. Waksman, R., Erbel, R., Di Mario, C., Bartunek, J., de Bruyne, B., Eberli, F.R., Erne, P., Haude, M., Horrigan, M., Ilsley, C., Böse, D., Bonnier, H., Koolen, J., Lüscher, T.F., Weissman, N.J. JACC. Cardiovasc. Interv (2009) [Pubmed]
  8. Effects of exogenous peripheral-blood-derived endothelial progenitor cells or unfractionated bone-marrow-derived cells on neointimal formation and inflammation in cholesterol-fed, balloon-denuded, and radiated iliac arteries of inbred rabbits. Waksman, R., Baffour, R., Pakala, R., Scheinowitz, M., Hellinga, D., Seabron, R., Chan, R., Kolodgie, F., Virmani, R. Cardiovasc. Revasc. Med (2009) [Pubmed]
  9. Definition, incidence, correlates, and clinical impact of "nuisance" bleeding in patients undergoing drug-eluting stent implantation. Waksman, R. Am. J. Cardiol. (2009) [Pubmed]
  10. Drug-eluting balloon: the comeback kid?. Waksman, R., Pakala, R. Circ. Cardiovasc. Interv (2009) [Pubmed]
  11. Short-term effects of biocorrodible iron stents in porcine coronary arteries. Waksman, R., Pakala, R., Baffour, R., Seabron, R., Hellinga, D., Tio, F.O. J. Interv. Cardiol (2008) [Pubmed]
  12. Effect of clopidogrel on neointimal formation and inflammation in balloon-denuded and radiated hypercholesterolemic rabbit iliac arteries. Waksman, R., Pakala, R., Roy, P., Baffour, R., Hellinga, D., Seabron, R., Chan, R., Scheinowitz, M., Kolodgie, F., Virmani, R. J. Interv. Cardiol (2008) [Pubmed]
  13. PhotoPoint photodynamic therapy promotes stabilization of atherosclerotic plaques and inhibits plaque progression. Waksman, R., McEwan, P.E., Moore, T.I., Pakala, R., Kolodgie, F.D., Hellinga, D.G., Seabron, R.C., Rychnovsky, S.J., Vasek, J., Scott, R.W., Virmani, R. J. Am. Coll. Cardiol. (2008) [Pubmed]
  14. Drug-eluting stents: is new necessarily better?. Waksman, R. Lancet (2008) [Pubmed]
  15. Efficacy and safety of absorbable metallic stents with adjunct intracoronary beta radiation in porcine coronary arteries. Waksman, R., Pakala, R., Okabe, T., Hellinga, D., Chan, R., Tio, M.O., Wittchow, E., Hartwig, S., Waldmann, K.H., Harder, C. J. Interv. Cardiol (2007) [Pubmed]
  16. Long-term clinical outcomes and thrombosis rates of sirolimus-eluting versus paclitaxel-eluting stents in an unselected population with coronary artery disease (REWARDS registry). Waksman, R., Buch, A.N., Torguson, R., Xue, Z., Smith, K., Javaid, A., Chu, W.W., Satler, L.F., Kent, K.M., Pichard, A.D. Am. J. Cardiol. (2007) [Pubmed]
  17. Efficacy and safety of pimecrolimus-eluting stents in porcine coronary arteries. Waksman, R., Pakala, R., Baffour, R., Hellinga, D., Seabron, R., Tio, F.O., Wittchow, E., Tittelbach, M., Diener, T., Harder, C., Virmani, R., Jones, R. Cardiovasc. Revasc. Med (2007) [Pubmed]
  18. ACUITY-PCI: one drug does not fit all. Waksman, R. Lancet (2007) [Pubmed]
  19. Drug-eluting stent thrombosis vs bare metal stent restenosis: finding the lesser of two evils. Steinberg, D.H., Waksman, R. Am. Heart. Hosp. J (2007) [Pubmed]
  20. Promise and challenges of bioabsorbable stents. Waksman, R. Catheter. Cardiovasc. Interv (2007) [Pubmed]
  21. Optimal dosing and duration of oral everolimus to inhibit in-stent neointimal growth in rabbit iliac arteries. Waksman, R., Pakala, R., Baffour, R., Hellinga, D., Seabron, R., Kolodgie, F., Virmani, R. Cardiovasc. Revasc. Med (2006) [Pubmed]
  22. Intracoronary photodynamic therapy reduces neointimal growth without suppressing re-endothelialisation in a porcine model. Waksman, R., Leitch, I.M., Roessler, J., Yazdi, H., Seabron, R., Tio, F., Scott, R.W., Grove, R.I., Rychnovsky, S., Robinson, B., Pakala, R., Cheneau, E. Heart (2006) [Pubmed]
  23. Safety and efficacy of bioabsorbable magnesium alloy stents in porcine coronary arteries. Waksman, R., Pakala, R., Kuchulakanti, P.K., Baffour, R., Hellinga, D., Seabron, R., Tio, F.O., Wittchow, E., Hartwig, S., Harder, C., Rohde, R., Heublein, B., Andreae, A., Waldmann, K.H., Haverich, A. Catheter. Cardiovasc. Interv (2006) [Pubmed]
  24. Update on bioabsorbable stents: from bench to clinical. Waksman, R. J. Interv. Cardiol (2006) [Pubmed]
  25. Contemporary Use of Drug-eluting Stents. Chu, W.W., Waksman, R. Curr. Treat. Options. Cardiovasc. Med (2005) [Pubmed]
  26. Drug-eluting stents versus repeat vascular brachytherapy for patients with recurrent in-stent restenosis after failed intracoronary radiation. Chu, W.W., Torguson, R., Pichard, A.D., Satler, L.F., Chan, R., Porrazzo, M., Kent, K.M., Suddath, W.O., Waksman, R. J. Invasive. Cardiol (2005) [Pubmed]
  27. Five-year follow-up after intracoronary gamma radiation therapy for in-stent restenosis. Waksman, R., Ajani, A.E., White, R.L., Chan, R., Bass, B., Pichard, A.D., Satler, L.F., Kent, K.M., Torguson, R., Deible, R., Pinnow, E., Lindsay, J. Circulation (2004) [Pubmed]
  28. Use of IIb/IIIa inhibitors in patients with in-stent restenosis treated with intracoronary gamma-radiation. Integrilin WRIST. Waksman, R., Ajani, A.E., Gruberg, L., Pinnow, E., GebreEyesus, A., Deible, R., Satler, L.F., Pichard, A.D., Torguson, R., Kent, K.M., Suddath, W., Lindsay, J. Catheter. Cardiovasc. Interv (2004) [Pubmed]
  29. Transepicardial autologous bone marrow-derived mononuclear cell therapy in a porcine model of chronically infarcted myocardium. Waksman, R., Fournadjiev, J., Baffour, R., Pakala, R., Hellinga, D., Leborgne, L., Yazdi, H., Cheneau, E., Wolfram, R., Seabron, R., Horton, K., Kolodgie, F., Virmani, R., Rivera, E. Cardiovasc. Radiat. Med. (2004) [Pubmed]
  30. Intracoronary radiation therapy improves the clinical and angiographic outcomes of diffuse in-stent restenotic lesions: results of the Washington Radiation for In-Stent Restenosis Trial for Long Lesions (Long WRIST) Studies. Waksman, R., Cheneau, E., Ajani, A.E., White, R.L., Pinnow, E., Torguson, R., Deible, R., Satler, L.F., Pichard, A.D., Kent, K.M., Teirstein, P.S., Lindsay, J. Circulation (2003) [Pubmed]
  31. Review of intracoronary radiation for in-stent restenosis. Lew, R., Ajani, A., Waksman, R. J. Invasive. Cardiol (2003) [Pubmed]
  32. Coronary brachytherapy in the drug-eluting stent era: don't bury it alive. Waksman, R., Weinberger, J. Circulation (2003) [Pubmed]
  33. Oral rapamycin inhibits growth of atherosclerotic plaque in apoE knock-out mice. Waksman, R., Pakala, R., Burnett, M.S., Gulick, C.P., Leborgne, L., Fournadjiev, J., Wolfram, R., Hellinga, D. Cardiovasc. Radiat. Med. (2003) [Pubmed]
  34. Repeat intracoronary radiation for recurrent in-stent restenosis in patients who failed intracoronary radiation. Waksman, R., Lew, R., Ajani, A.E., Pichard, A.D., Satler, L.F., Kent, K.M., Chan, R., White, R.L., Suddath, W.O., Pinnow, E., Torguson, R., Dilcher, C., Wolfram, R., Lindsay, J. Circulation (2003) [Pubmed]
  35. Beta emitter systems and results from clinical trials. state of the art. Waksman, R., Raizner, A., Popma, J.J. Cardiovasc. Radiat. Med. (2003) [Pubmed]
  36. Bone marrow and bone marrow derived mononuclear stem cells therapy for the chronically ischemic myocardium. Waksman, R., Baffour, R. Cardiovasc. Radiat. Med. (2003) [Pubmed]
  37. Use of localised intracoronary beta radiation in treatment of in-stent restenosis: the INHIBIT randomised controlled trial. Waksman, R., Raizner, A.E., Yeung, A.C., Lansky, A.J., Vandertie, L. Lancet (2002) [Pubmed]
  38. Intravascular gamma radiation for in-stent restenosis in saphenous-vein bypass grafts. Waksman, R., Ajani, A.E., White, R.L., Chan, R.C., Satler, L.F., Kent, K.M., Pichard, A.D., Pinnow, E.E., Bui, A.B., Ramee, S., Teirstein, P., Lindsay, J. N. Engl. J. Med. (2002) [Pubmed]
  39. Twelve versus six months of clopidogrel to reduce major cardiac events in patients undergoing gamma-radiation therapy for in-stent restenosis: Washington Radiation for In-Stent restenosis Trial (WRIST) 12 versus WRIST PLUS. Waksman, R., Ajani, A.E., Pinnow, E., Cheneau, E., Leborgne, L., Dieble, R., Bui, A.B., Satler, L.F., Pichard, A.D., Kent, K.K., Lindsay, J. Circulation (2002) [Pubmed]
  40. Balloon-based radiation therapy for treatment of in-stent restenosis in human coronary arteries: results from the BRITE I study. Waksman, R., Buchbinder, M., Reisman, M., Lansky, A.J., Trauthen, B., Whiting, J., Li, A. Catheter. Cardiovasc. Interv (2002) [Pubmed]
  41. Drug-eluting stents: from bench to bed. Waksman, R. Cardiovasc. Radiat. Med. (2002) [Pubmed]
WikiGenes - Universities